BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 17253909)

  • 1. Predictors of in-hospital mortality for bloodstream infections caused by Enterobacter species or Citrobacter freundii.
    Deal EN; Micek ST; Ritchie DJ; Reichley RM; Dunne WM; Kollef MH
    Pharmacotherapy; 2007 Feb; 27(2):191-9. PubMed ID: 17253909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN; Micek ST; Reichley RM; Ritchie DJ
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bloodstream infections caused by Enterobacter species: predictors of 30-day mortality rate and impact of broad-spectrum cephalosporin resistance on outcome.
    Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Oh MD; Kim EC; Choe KW
    Clin Infect Dis; 2004 Sep; 39(6):812-8. PubMed ID: 15472813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and predictors of mortality in patients with Enterobacter aerogenes bacteremia.
    Chang EP; Chiang DH; Lin ML; Chen TL; Wang FD; Liu CY
    J Microbiol Immunol Infect; 2009 Aug; 42(4):329-35. PubMed ID: 19949757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enterobacter bacteremia: Clinical features, risk factors for multiresistance and mortality in a Chinese University Hospital.
    Ye Y; Li JB; Ye DQ; Jiang ZJ
    Infection; 2006 Oct; 34(5):252-7. PubMed ID: 17033748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of previous use of antibiotics on development of resistance to extended-spectrum cephalosporins in patients with enterobacter bacteremia.
    Lee SO; Kim YS; Kim BN; Kim MN; Woo JH; Ryu J
    Eur J Clin Microbiol Infect Dis; 2002 Aug; 21(8):577-81. PubMed ID: 12226687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enterobacter meningitis: organism susceptibilities, antimicrobial therapy and related outcomes.
    Foster DR; Rhoney DH
    Surg Neurol; 2005 Jun; 63(6):533-7; discussion 537. PubMed ID: 15936376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the clinical significance of production of extended-spectrum beta-lactamases (ESBL) by Enterobacteriaceae.
    Henshke-Bar-Meir R; Yinnon AM; Rudensky B; Attias D; Schlesinger Y; Raveh D
    Infection; 2006 Apr; 34(2):66-74. PubMed ID: 16703295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic inflammatory response syndrome in nosocomial bloodstream infections with Pseudomonas aeruginosa and Enterococcus Species: comparison of elderly and nonelderly patients.
    Marra AR; Bar K; Bearman GM; Wenzel RP; Edmond MB
    J Am Geriatr Soc; 2006 May; 54(5):804-8. PubMed ID: 16696747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial resistance in nosocomial bloodstream infection associated with pneumonia and the value of systematic surveillance cultures in an adult intensive care unit.
    Depuydt PO; Blot SI; Benoit DD; Claeys GW; Verschraegen GL; Vandewoude KH; Vogelaers DP; Decruyenaere JM; Colardyn FA
    Crit Care Med; 2006 Mar; 34(3):653-9. PubMed ID: 16505649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and risk factors for attributable mortality in Enterobacter cloacae bacteremia.
    Lin YC; Chen TL; Ju HL; Chen HS; Wang FD; Yu KW; Liu CY
    J Microbiol Immunol Infect; 2006 Feb; 39(1):67-72. PubMed ID: 16440126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for predicting mortality in a surgical intensive care unit in the year 2000.
    Bunburaphong P; Chatrkaw P; Sriprachittichai P; Supleornsug K; Ultchaswadi P; Sumetha-Aksorn N
    J Med Assoc Thai; 2003 Jan; 86(1):8-15. PubMed ID: 12678134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and diversity of qnr alleles in AmpC-producing Enterobacter cloacae, Enterobacter aerogenes, Citrobacter freundii and Serratia marcescens: a multicentre study from Korea.
    Park YJ; Yu JK; Lee S; Oh EJ; Woo GJ
    J Antimicrob Chemother; 2007 Oct; 60(4):868-71. PubMed ID: 17660263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors and outcomes of antibiotic adequacy for bloodstream infections in veterans with spinal cord injury.
    Evans CT; Burns SP; Chin A; Weaver FM; Hershow RC
    Arch Phys Med Rehabil; 2009 Aug; 90(8):1364-70. PubMed ID: 19651270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins.
    de Kraker ME; Wolkewitz M; Davey PG; Koller W; Berger J; Nagler J; Icket C; Kalenic S; Horvatic J; Seifert H; Kaasch A; Paniara O; Argyropoulou A; Bompola M; Smyth E; Skally M; Raglio A; Dumpis U; Melbarde Kelmere A; Borg M; Xuereb D; Ghita MC; Noble M; Kolman J; Grabljevec S; Turner D; Lansbury L; Grundmann H
    J Antimicrob Chemother; 2011 Feb; 66(2):398-407. PubMed ID: 21106563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical relevance of Enterobacter infections.
    Shlaes DM
    Clin Ther; 1993; 15 Suppl A():21-8. PubMed ID: 8513457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bloodstream infections caused by qnr-positive Enterobacteriaceae: clinical and microbiologic characteristics and outcomes.
    Chong YP; Choi SH; Kim ES; Song EH; Lee EJ; Park KH; Cho OH; Kim SH; Lee SO; Kim MN; Jeong JY; Woo JH; Kim YS
    Diagn Microbiol Infect Dis; 2010 May; 67(1):70-7. PubMed ID: 20227228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender impact on the outcomes of critically ill patients with nosocomial infections.
    Combes A; Luyt CE; Trouillet JL; Nieszkowska A; Chastre J
    Crit Care Med; 2009 Sep; 37(9):2506-11. PubMed ID: 19602974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restriction of third-generation cephalosporin use decreases infection-related mortality.
    Du B; Chen D; Liu D; Long Y; Shi Y; Wang H; Rui X; Cui N
    Crit Care Med; 2003 Apr; 31(4):1088-93. PubMed ID: 12682477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to extended-spectrum cephalosporins and mortality in patients with Citrobacter freundii bacteremia.
    Kim BN; Woo JH; Ryu J; Kim YS
    Infection; 2003 Aug; 31(4):202-7. PubMed ID: 14562942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.